인쇄하기
취소

KPA mulls strengthened DUR-related drug guidance functions

Published: 2004-06-03 06:57:00
Updated: 2004-06-03 06:57:00
The Korea Pharmaceutical Association is considering the establishment of a DUR (drug utilization review)-related consultative body and its subcommittee in an attempt to voluntarily make the DUR road map for better drug guidance.

The DUR is a process whereby a variety of medications the elder takes everything from OTC products and herbal remedies to prescriptions are examined to see if they...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.